Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | -8.76% |
|
+0.50% | -90.24% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-90.24% | 64.73M | |
+38.08% | 53.67B | |
+33.67% | 38.86B | |
-8.06% | 38.76B | |
-10.77% | 27.27B | |
+11.31% | 25.91B | |
-15.91% | 20.29B | |
+33.73% | 12.78B | |
+28.06% | 12.18B | |
-2.77% | 11.96B |
- Stock Market
- Equities
- ANTX Stock
- News AN2 Therapeutics, Inc.
- Oppenheimer Adjusts AN2 Therapeutics Price Target to $27 From $24, Maintains Outperform Rating